Pharmalicensing.com
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register

Our Products
Overview
Partnering Search
Company Profiling
Partneringtools
Reports
Partnering Consulting
Comparison
 
Forums
Visit our forums
 
Jobs
Visit our job site
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire New!
 
Contact us
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Pharmalicensing Ltd
is a division of
UTEK Corporation
Companies

Beacon Pharmaceuticals

Pharmaceutical sales to the UK hospital market.

The company in detail

Profile

Beacon is a specialist pharmaceutical company based in the UK that focuses on niche opportunities within the hospital market. Current therapeutic areas of specialization include:- epilepsy, oncology, anaesthetics, infectious disease, dermatology and intensive care.

Beacon has several hospital products that are well established in its markets and is continuing to respond well to promotion by its team of Hospital Representatives.

Beacon is well positioned to partner with other companies to successfully commercialize products in a wide range of therapeutic areas and market settings. The company has a dedicated team committed to ensuring success, particularly in niche markets that are less attractive to multinational corporations.

Partnering strategy/interests

Beacon has a two pronged strategy primarily aimed at the UK Hospital Market: -

1. Partnering with organisations to successfully commercialise products.

2. The acquisition of the non-strategic products from established pharmaceutical companies.

Out-licensing

Proguanil & Chloroquine preparations More

In-licensing

Seeking licensing opportunities for the UK hospital market More
Acquisition of established pharmaceuticals in the UK market More
In-licensing of pharmaceuticals targeted at Anaesthetists in the UK More
Oncology products required for in-licensing or acquisition More
Seeking to in-licensing blood products or similiar for the UK hospital market More

R&D

To view this information, you must subscribe to Partneringtools.

Partnerships

To view this information, you must subscribe to Partneringtools.

Deals

To view this information, you must subscribe to Partneringtools.

Press Releases

(12th Jan 2004) Protherics PLC announces European deal for DigiFab with Beacon Pharmaceuticals Ltd. More
(1st Dec 2003) Sales of the mucolytic Mucodyne grow after Beacon successfully negotiates reimbursement in the UK. More
(15th Oct 2002) Questcor Pharmaceuticals has signed an agreement with Beacon Pharmaceuticals of Tunbridge Wells, Kent, UK, for the exclusive marketing and distribution of H.P. Acthar(R) Gel in the United Kingdom. More

Head office

Beacon Pharmaceuticals
85 High Street
Tunbridge Wells
Kent
TN1 1YG
United Kingdom

Tel:  (44) (0)1892 506958
Fax: (44) (0)1892 610397
www | email

Contact details

Dr Steven Short
Managing Director
Executive
Request more information

Company figures

Formed: 2000
Annual Turnover: €10,300,000 (2004)
Number of employees: 14

Regional and subsidiary offices

Beacon Pharmaceuticals Ltd
The Regent
The Broadway
Crowborough
East Sussex
TN6 1DA
United Kingdom

Tel:  +44 01892 600930
Fax: +44 01892 600937
www | email

Related categories

Partnering consultation free of charge
Pharma Business Strategies for Biomarkers
Need competitive intelligence information
Industry news: Pharmalicensing provides comprehensive industry coverage.

© Copyright 1995-2008 Pharmalicensing Ltd, is a division of UTEK Corporation All rights reserved. Terms and Conditions | Site map | Contact us